777 related articles for article (PubMed ID: 27393664)
1. MAIT, MR1, microbes and riboflavin: a paradigm for the co-evolution of invariant TCRs and restricting MHCI-like molecules?
Mondot S; Boudinot P; Lantz O
Immunogenetics; 2016 Aug; 68(8):537-48. PubMed ID: 27393664
[TBL] [Abstract][Full Text] [Related]
2. MHC class I-related molecule, MR1, and mucosal-associated invariant T cells.
Franciszkiewicz K; Salou M; Legoux F; Zhou Q; Cui Y; Bessoles S; Lantz O
Immunol Rev; 2016 Jul; 272(1):120-38. PubMed ID: 27319347
[TBL] [Abstract][Full Text] [Related]
3. Human TRAV1-2-negative MR1-restricted T cells detect S. pyogenes and alternatives to MAIT riboflavin-based antigens.
Meermeier EW; Laugel BF; Sewell AK; Corbett AJ; Rossjohn J; McCluskey J; Harriff MJ; Franks T; Gold MC; Lewinsohn DM
Nat Commun; 2016 Aug; 7():12506. PubMed ID: 27527800
[TBL] [Abstract][Full Text] [Related]
4. MAIT cells and MR1-antigen recognition.
Keller AN; Corbett AJ; Wubben JM; McCluskey J; Rossjohn J
Curr Opin Immunol; 2017 Jun; 46():66-74. PubMed ID: 28494326
[TBL] [Abstract][Full Text] [Related]
5. Antigen Recognition by MR1-Reactive T Cells; MAIT Cells, Metabolites, and Remaining Mysteries.
Corbett AJ; Awad W; Wang H; Chen Z
Front Immunol; 2020; 11():1961. PubMed ID: 32973800
[TBL] [Abstract][Full Text] [Related]
6. Human MAIT-cell responses to Escherichia coli: activation, cytokine production, proliferation, and cytotoxicity.
Dias J; Sobkowiak MJ; Sandberg JK; Leeansyah E
J Leukoc Biol; 2016 Jul; 100(1):233-40. PubMed ID: 27034405
[TBL] [Abstract][Full Text] [Related]
7. T-cell activation by transitory neo-antigens derived from distinct microbial pathways.
Corbett AJ; Eckle SB; Birkinshaw RW; Liu L; Patel O; Mahony J; Chen Z; Reantragoon R; Meehan B; Cao H; Williamson NA; Strugnell RA; Van Sinderen D; Mak JY; Fairlie DP; Kjer-Nielsen L; Rossjohn J; McCluskey J
Nature; 2014 May; 509(7500):361-5. PubMed ID: 24695216
[TBL] [Abstract][Full Text] [Related]
8. Mucosal-associated invariant T cell receptor recognition of small molecules presented by MR1.
Awad W; Le Nours J; Kjer-Nielsen L; McCluskey J; Rossjohn J
Immunol Cell Biol; 2018 Jul; 96(6):588-597. PubMed ID: 29393543
[TBL] [Abstract][Full Text] [Related]
9. Mouse mucosal-associated invariant T cell receptor recognition of MR1 presenting the vitamin B metabolite, 5-(2-oxopropylideneamino)-6-d-ribitylaminouracil.
Ciacchi L; Mak JYW; Le JP; Fairlie DP; McCluskey J; Corbett AJ; Rossjohn J; Awad W
J Biol Chem; 2024 May; 300(5):107229. PubMed ID: 38537698
[TBL] [Abstract][Full Text] [Related]
10. Tuning of human MAIT cell activation by commensal bacteria species and MR1-dependent T-cell presentation.
Tastan C; Karhan E; Zhou W; Fleming E; Voigt AY; Yao X; Wang L; Horne M; Placek L; Kozhaya L; Oh J; Unutmaz D
Mucosal Immunol; 2018 Nov; 11(6):1591-1605. PubMed ID: 30115998
[TBL] [Abstract][Full Text] [Related]
11. MR1 presentation of vitamin B-based metabolite ligands.
McWilliam HE; Birkinshaw RW; Villadangos JA; McCluskey J; Rossjohn J
Curr Opin Immunol; 2015 Jun; 34():28-34. PubMed ID: 25603223
[TBL] [Abstract][Full Text] [Related]
12. T cell receptor diversity, specificity and promiscuity of functionally heterogeneous human MR1-restricted T cells.
Lepore M; Lewinsohn DA; Lewinsohn DM
Mol Immunol; 2021 Feb; 130():64-68. PubMed ID: 33360378
[TBL] [Abstract][Full Text] [Related]
13. Functional Heterogeneity and Antimycobacterial Effects of Mouse Mucosal-Associated Invariant T Cells Specific for Riboflavin Metabolites.
Sakala IG; Kjer-Nielsen L; Eickhoff CS; Wang X; Blazevic A; Liu L; Fairlie DP; Rossjohn J; McCluskey J; Fremont DH; Hansen TH; Hoft DF
J Immunol; 2015 Jul; 195(2):587-601. PubMed ID: 26063000
[TBL] [Abstract][Full Text] [Related]
14. Diverse MR1-restricted T cells in mice and humans.
Koay HF; Gherardin NA; Xu C; Seneviratna R; Zhao Z; Chen Z; Fairlie DP; McCluskey J; Pellicci DG; Uldrich AP; Godfrey DI
Nat Commun; 2019 May; 10(1):2243. PubMed ID: 31113973
[TBL] [Abstract][Full Text] [Related]
15. The molecular basis for Mucosal-Associated Invariant T cell recognition of MR1 proteins.
López-Sagaseta J; Dulberger CL; Crooks JE; Parks CD; Luoma AM; McFedries A; Van Rhijn I; Saghatelian A; Adams EJ
Proc Natl Acad Sci U S A; 2013 May; 110(19):E1771-8. PubMed ID: 23613577
[TBL] [Abstract][Full Text] [Related]
16. Drugs and drug-like molecules can modulate the function of mucosal-associated invariant T cells.
Keller AN; Eckle SB; Xu W; Liu L; Hughes VA; Mak JY; Meehan BS; Pediongco T; Birkinshaw RW; Chen Z; Wang H; D'Souza C; Kjer-Nielsen L; Gherardin NA; Godfrey DI; Kostenko L; Corbett AJ; Purcell AW; Fairlie DP; McCluskey J; Rossjohn J
Nat Immunol; 2017 Apr; 18(4):402-411. PubMed ID: 28166217
[TBL] [Abstract][Full Text] [Related]
17. Characterization of Human Mucosal-associated Invariant T (MAIT) Cells.
Souter MNT; Loh L; Li S; Meehan BS; Gherardin NA; Godfrey DI; Rossjohn J; Fairlie DP; Kedzierska K; Pellicci DG; Chen Z; Kjer-Nielsen L; Corbett AJ; McCluskey J; Eckle SBG
Curr Protoc Immunol; 2019 Dec; 127(1):e90. PubMed ID: 31763790
[TBL] [Abstract][Full Text] [Related]
18. A molecular basis underpinning the T cell receptor heterogeneity of mucosal-associated invariant T cells.
Eckle SB; Birkinshaw RW; Kostenko L; Corbett AJ; McWilliam HE; Reantragoon R; Chen Z; Gherardin NA; Beddoe T; Liu L; Patel O; Meehan B; Fairlie DP; Villadangos JA; Godfrey DI; Kjer-Nielsen L; McCluskey J; Rossjohn J
J Exp Med; 2014 Jul; 211(8):1585-600. PubMed ID: 25049336
[TBL] [Abstract][Full Text] [Related]
19. MAITs, MR1 and vitamin B metabolites.
Birkinshaw RW; Kjer-Nielsen L; Eckle SB; McCluskey J; Rossjohn J
Curr Opin Immunol; 2014 Feb; 26():7-13. PubMed ID: 24556396
[TBL] [Abstract][Full Text] [Related]
20. How MR1 Presents a Pathogen Metabolic Signature to Mucosal-Associated Invariant T (MAIT) Cells.
McWilliam HEG; Villadangos JA
Trends Immunol; 2017 Sep; 38(9):679-689. PubMed ID: 28688841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
